Howard Lee, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 54,350 shares at $21.84 ($1.2M) on 2018-12-04, disclosed to the SEC on 2018-12-07.
Open-market sale of $1.2M AMPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.84 | 8,989 | $196K | 16.6% |
| 2 | $21.85 | 8,989 | $196K | 16.6% |
| 3 | $22.55 | 1,011 | $23K | 1.9% |
| 4 | $22.55 | 1,011 | $23K | 1.9% |
| 5 | $20.91 | 4,206 | $88K | 7.4% |
| 6 | $21.45 | 5,794 |
| $124K |
| 10.5% |
| 7 | $21.45 | 5,794 | $124K | 10.5% |
| 8 | $21.89 | 9,278 | $203K | 17.2% |
| 9 | $21.89 | 9,278 | $203K | 17.2% |
| Total | $21.73 avg | 54,350 | $1.2M | 100% |
| Filing → |
| AMPH | SELL | 2022-05-25 | $349K | — | Filing → |
| AMPH | SELL | 2021-06-08 | $456K | — | Filing → |
| AMPH | SELL | 2021-05-24 | $395K | — | Filing → |